Company profile
Seaweed Component Extraction | Marine Biopolymers Ltd - MBL
Marine Biopolymers use seaweed components extraction to develop a range of products with specific properties for a broad range of uses with human benefits.
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
CS01 | Transaction MzQ0MTczOTE2NmFkaXF6a2N4
Published 01 Nov 2024 11:02
Last accounts made up date
Company registered at Companies House
1 Feb 2026 to 31 Mar 2026
UK Healthcare costs, both direct and indirect, increase remorselessly absorbing tens of billion £ pa (Obesity ~ £10 B, Coronary Disease ~ £25 B), and whilst treatments and outcomes improve, the validity of different approaches is recognised -- prevention better, and cheaper, than cure. Individual responsibility matters, albeit governments are acutely awar...
1 Jun 2024 to 30 Nov 2025
This project, Alginic-acid to Safety ("A2S"), centres on the transformation of a key product from seaweed processing, Alginic Acid ("AA"), into novel materials ("Starbon") with superior performance in the field of toxic gas filtration. Scotland has a long history with seaweed processing dating back to the 18th century. Although primary Alginate production...
1 Jul 2023 to 31 Dec 2023
The climate crisis is a serious global threat of immediate political importance internationally. Limiting future environmental degradation, severe weather events and declining biodiversity whilst securing future supplies of fuel, food, water and crops is essential. A global effort is needed to achieve the United Nations goal of Net Zero emissions by 2050\...
1 Sep 2012 to 31 Oct 2013
Awaiting Public Project Summary
1 May 2011 to 31 Jul 2011
Awaiting Public Summary
